TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) Gross margin 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) gross margin by fiscal year — reported gross profit divided by reported revenue.
51.8%FY2025 · since FY2016: 53.2% → 51.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 51.8% | +3.0 pp |
| FY2024 | 48.7% | +0.5 pp |
| FY2023 | 48.2% | +1.5 pp |
| FY2022 | 46.7% | -1.1 pp |
| FY2021 | 47.8% | +1.4 pp |
| FY2020 | 46.4% | +1.7 pp |
| FY2019 | 44.6% | -0.8 pp |
| FY2018 | 45.4% | -3.2 pp |
| FY2017 | 48.6% | -4.6 pp |
| FY2016 | 53.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice